Thermo Fisher Scientific has opened a new cutting-edge facility in Runcorn, Cheshire.
Thermo Fisher Scientific has opened a new cutting-edge facility in Runcorn, Cheshire. The new facility represents a significant investment for the company and is a new designated Centre of Excellence for its Anatomical Pathology business.
The new facility is the company’s largest in the North of England and one of its biggest in the UK, with products and services to improve the detection and diagnosis of cancer and advance research for drug development. It is also a manufacturing centre for the company’s Chromatography Consumables business. These products are used in laboratories specializing in chromatography and mass spectrometry analysis. They enable detection, quantification and isolation of complex sample mixtures that are commonly encountered in pharmaceutical, environmental, biomedical, chemical, toxicology, forensics and food safety industries. The technology developed in Runcorn enables the company to meet demands for more specific and sensitive yet robust testing to support its customers.
In a statement, Giulio Cerroni, the company’s vice president of Anatomical Pathology commercial operations in Europe, the Middle East and Asia Pacific, said of the new facility: “We are delighted to announce the opening of the new facility in Runcorn, Cheshire. This is an important investment for the company, and we are already considering the next phase of development for the site. The new facility in Runcorn demonstrates the company’s commitment to better serving our customers by investing in the future of the business.”
The new facility was officially opened by Dr Yuh-geng Tsay, president, Specialty Diagnostics and Dr Roger Platt, chairman, Northwest Science Council.
For more information about the new Runcorn facility visit www.thermo.com
Get essential updates on the latest spectroscopy technologies, regulatory standards, and best practices—subscribe today to Spectroscopy.
AI-Powered Raman with CARS Offers Laser Imaging for Rapid Cervical Cancer Diagnosis
July 15th 2025Chinese researchers have developed a cutting-edge cervical cancer diagnostic model that combines spontaneous Raman spectroscopy, CARS imaging, and artificial intelligence to achieve 100% accuracy in distinguishing healthy and cancerous tissue.
How Analytical Chemists Are Navigating DOGE-Driven Funding Cuts
July 14th 2025DOGE-related federal funding cuts have sharply reduced salaries, lab budgets, and graduate support in academia. Researchers view the politically driven shifts in priorities as part of recurring systemic issues in U.S. science funding during administrative transitions. The impact on Federal laboratories has varied, with some seeing immediate effects and others experiencing more gradual effects. In general, there is rising uncertainty over future appropriations. Sustainable recovery may require structural reforms, leaner administration, and stronger industry-academia collaboration. New commentary underscores similar challenges, noting scaled-back graduate admissions, spending freezes, and a pervasive sense of overwhelming stress among faculty, students, and staff. This article addresses these issues for the analytical chemistry community.